EnsiliTech founder Dr Asel Sartbaeva has been featured by the United Nations for work on making life-saving biologics accessible worldwide.
Vaccines, antibodies and other biologics depend on a 50-year-old global cold chain that costs over $35bn a year and remains a major barrier to access.
